NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Simvastatin as a Potential Breakthrough Therapy – Reed Biotech LTD
Mar 30, 2026, 12:50

Simvastatin as a Potential Breakthrough Therapy – Reed Biotech LTD

Reed Biotech LTD shared a post on LinkedIn:

“New Research Alert!

Excited to share this impactful study from Shandong University, published in Advanced Healthcare Materials (IF=9.6), exploring simvastatin as a promising therapeutic for obstetric antiphospholipid syndrome (OAPS)!

Using a placenta-on-a-chip model + in vivo experiments, the team found that simvastatin:

  • Alleviates maternal vascular inflammation
  • Restores abnormal uteroplacental hemodynamics
  • Promotes trophoblast invasion and  spiral artery remodeling
  • Improves placental perfusion

Mechanistically, these effects are mediated via activating the KLF2/eNOS signaling pathway in vascular endothelial cells.

This work highlights simvastatin as a potential candidate for treating refractory OAPS—great progress for reproductive medicine!

DOI: 10.1002/adhm.202504027″

Simvastatin as a Potential Breakthrough Therapy – Reed Biotech LTD

Stay updated on all scientific advances in the field of fertility with Fertility News.

abnormal uteroplacental hemodynamics Advanced Healthcare Materials Fertility Fertility News impactful study KLF2/eNOS maternal vascular inflammation OAPS obstetric antiphospholipid syndrome placenta-on-a-chip model placental perfusion Reed Biotech LTD reproductive health Reproductive Medicine Shandong University simvastatin spiral artery remodeling trophoblast invasion vascular endothelial cells
NewsFeed